A new synthetic pathway to dinapsoline has been designed

dinapsoline and dinoxyline are drugs moleculars for treatment of Parkinson's disease, the traditional synthetic pathway to those drugs moleculars need more than 10 steps and cannot control the enantioselectivities, in additions, it also involve a lot of toxic chemical. So, here I design a new synthetic pathway that can synthesis the same molecule with fewer steps and up to 84% ee.

Comments

Post a Comment

Popular posts from this blog

Ruthenium-Catalyzed Enantioselective C–H Functionalization: A Practical Access to Optically Active Indoline Derivatives

This paper provide a new synthetic strategy to syntheis indoline derivatives by using commercial available chiral transient amine, gives a good ee( up to 94%) and also shows some potential application to some drug molecules. It provide a practical way to control the intramolecular enantioselective C-H activation. https://pubs.acs.org/doi/10.1021/jacs.9b07251
Read more